Clinical Trials Detalhe
Study of the Efficacy and Safety of MEDI4893
General Information
Gender
ALL
Age
from 18 Years to 130 Years
Phase
PHASE2
Study Type
INTERVENTIONAL
Location
Research Site (Ponte de Lima, Portugal)
Clinicaltrial.gov
https://classic.clinicaltrials.gov/ct2/show/NCT02296320Summary
Clinical trial looking at safety and efficacy of MEDI4893 in prevention of pneumonia caused by Staphylococcus aureus in high-risk patients
Conditions
Staphylococcus Aureus Pneumonia
Eligibility
Inclusion Criteria: * Colonized with Staphylococcus aureus, expected to require prolonged intubation and mechanical ventilation, without any evidence of active pneumonia. Exclusion Criteria: * Staphylococcal disease at randomisation; lung injury score consistent with pneumonia; current lung disease; chronic tracheostomy patients; currently receiving systemic anti-staphylococcal antibiotics; moribund patients.